Skip to content
COVID-19 Pivot: EpiChem’s Novel Response episode artwork

Apr 16, 2020 17 min

COVID-19 Pivot: EpiChem’s Novel Response

from The AUScelerate Podcast Hosted by MTPConnect

In this current COVID-19 climate, companies are pivoting and stepping-up to meet industry challenges. Continuing discussions in our virtual podcast studio, host Caroline Duell and Dr Kate Brooks are joined by Epichem CEO, Colin La Galia, to talk about what his chemistry services company is doing to support healthcare teams on the COVID-19 frontline in WA. EpiChem is pivoting to produce WHO formulated chemistry-grade hand sanitiser for hospitals and aged care centres in Western Australia. Colin outlines the ripple effect of the global pandemic on the business and associated industries involved in drug discovery & clinical trials, and how EpiChem is supporting homegrown careers in chemistry to build scientific capability.

Episode details come from the podcast's RSS feed.

Embed this episode

In this current COVID-19 climate, companies are pivoting and stepping-up to meet industry challenges. Continuing discussions in our virtual podcast studio, host Caroline Duell and Dr Kate Brooks are joined by Epichem CEO, Colin La Galia, to talk about what his chemistry services company is doing to support healthcare teams on the COVID-19 frontline in WA. EpiChem is pivoting to produce WHO formulated chemistry-grade hand sanitiser for hospitals and aged care centres in Western Australia. Coli...

Ready to play

COVID-19 Pivot: EpiChem’s Novel Response

0:00 17:49

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The AUScelerate Podcast?

This episode is 17 minutes long.

When was this The AUScelerate Podcast episode published?

This episode was published on April 16, 2020.

Can I download this The AUScelerate Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.